Menlo Park, CA, United States of America

Christina D Smolke

This inventor holds 40 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Benzylisoquinoline Alkaloids. Top assignees: California Institute of Technology, Leland Stanford Junior University, Antheia, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christina D Smolke. Retrieved from https://idiyas.com/inventor/christina-d-smolke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 (Patent Applications = 19)

% Patents Active = 82.5

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 3 (Patent Applications = 15)

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 124(Granted Patents)

Location History:

Stanford, CA (US) (2012 - 2015)
Pasadena, CA (US) (2012 - 2016)
Menlo Park, CA (US) (2013 - 2024)

Company Filing History:

16 out of 4,629

California Institute of Technology

patents

15 out of 5,515

Leland Stanford Junior University

Hercules Capital, Inc., as Agent

patents

5. 1 out of 692

Beckman Research Institute, City of Hope

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Benzylisoquinoline Alkaloids

Epimerases

Gene Expression Regulation

Microbial Production

Synthetic RNA

Aptamer Regulated

Morphinan Alkaloids

Modular Polynucleotides

Ligand-Responsive

Higher-Order Devices

Protein-Responsive

Molecular Sensors

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674185 - METHODS OF PRODUCING MORPHINAN ALKALOIDS AND DERIVATIVES (2026-07-07),

2. 12497638 - Methods of Producing Epimerases and Benzylisoquinoline Alkaloids (2025-12-16),

3. 12480131 - TROPANE ALKALOID (TA) PRODUCING NON-PLANT HOST CELLS, AND METHODS OF MAKING AND USING THE SAME (2025-11-25),

4. 12180525 - Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids (2024-12-31),

5. 12018304 - Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same (2024-06-25),

6. 11884949 - Methods of producing morphinan alkaloids and derivatives (2024-01-30),

7. 11859225 - Methods of producing epimerases and benzylisoquinoline alkaloids (2024-01-02),

8. 11427827 - Engineered benzylisoquinoline alkaloid epimerases and methods of producing benzylisoquinoline alkaloids (2022-08-30),

9. 11396668 - Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids (2022-07-26),

10. 11293020 - Molecular sensor selection (2022-04-05),

11. 11214819 - Benzylisoquinoline alkaloids (BIA) producing microbes, and methods of making and using the same (2022-01-04),

12. 11124814 - Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same (2021-09-21),

13. 10988787 - Benzylisoquinoline alkaloids (BIA) producing microbes, and methods of making and using the same (2021-04-27),

14. 10858681 - Benzylisoquinoline alkaloids (BIA) producing microbes, and methods of making and using the same (2020-12-08),

15. 10752903 - Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same (2020-08-25),

Title: Christina D Smolke - Pioneer in Biotechnology

Introduction: Christina D Smolke is a renowned inventor based in Menlo Park, CA, known for her groundbreaking work in the field of biotechnology.

Latest Patents: Christina D Smolke holds several patents related to synthetic biology and metabolic engineering, revolutionizing the way we approach drug development and sustainable manufacturing processes.

Career Highlights: With a Ph.D. in Chemical Engineering from the University of California, Berkeley, Smolke has had a distinguished career. She is a Professor at Stanford University and the CEO of a biotechnology company she co-founded.

Collaborations: Smolke has collaborated with leading research institutions, pharmaceutical companies, and government agencies to further the applications of her innovative technologies in various industries.

Conclusion: Christina D Smolke's contributions to biotechnology have had a profound impact on the field, paving the way for new advancements and applications in synthetic biology and metabolic engineering.

Profile summary based on public USPTO records.